| 1 |
Hu J, Afayibo DJA, Zhang B, Zhu H, Yao L, Guo W, Wang X, Wang Z, Wang D, Peng H, Tian M, Qi J, Wang S. Characteristics, pathogenic mechanism, zoonotic potential, drug resistance, and prevention of avian pathogenic Escherichia coli (APEC). Front Microbiol 2022;13:1049391. [PMID: 36583051 DOI: 10.3389/fmicb.2022.1049391] [Reference Citation Analysis]
|
| 2 |
Jabłuszewski R, Wyszyńska A. Współczesne Metody Identyfikacji Białkowych Antygenów Szczepionkowych. Postępy Mikrobiologii - Advancements of Microbiology 2022;61:211-221. [DOI: 10.2478/am-2022-022] [Reference Citation Analysis]
|
| 3 |
Silva HGDS, Franzolin MR, Anjos GFD, Barbosa AS, Santos LFD, Miranda KF, Marques RM, Souza MCLD, Piazza RMF, Domingos MDO. O55 Polysaccharides Are Good Antigen Targets for the Formulation of Vaccines against O55 STEC and Capsulated aEPEC Strains. Pathogens 2022;11:895. [DOI: 10.3390/pathogens11080895] [Reference Citation Analysis]
|
| 4 |
Riaz S, Steinsland H, Thorsing M, Andersen AZ, Boysen A, Hanevik K. Characterization of Glycosylation-Specific Systemic and Mucosal IgA Antibody Responses to Escherichia coli Mucinase YghJ (SslE). Front Immunol 2021;12. [DOI: 10.3389/fimmu.2021.760135] [Reference Citation Analysis]
|
| 5 |
Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS. The impact of human vaccines on bacterial antimicrobial resistance. A review. Environ Chem Lett 2021;:1-32. [PMID: 34602924 DOI: 10.1007/s10311-021-01274-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Luzuriaga MA, Herbert FC, Brohlin OR, Gadhvi J, Howlett T, Shahrivarkevishahi A, Wijesundara YH, Venkitapathi S, Veera K, Ehrman R, Benjamin CE, Popal S, Burton MD, Ingersoll MA, De Nisco NJ, Gassensmith JJ. Metal-Organic Framework Encapsulated Whole-Cell Vaccines Enhance Humoral Immunity against Bacterial Infection. ACS Nano 2021. [PMID: 34546723 DOI: 10.1021/acsnano.1c03092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 7 |
Thorsing M, Krogh TJ, Vitved L, Nawrocki A, Jakobsen R, Larsen MR, Chakraborty S, Bourgeois AL, Andersen AZ, Boysen A. Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential. Front Cell Infect Microbiol 2021;11:705468. [PMID: 34490144 DOI: 10.3389/fcimb.2021.705468] [Reference Citation Analysis]
|
| 8 |
Swietnicki W. Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens. Biomolecules 2021;11:892. [PMID: 34203937 DOI: 10.3390/biom11060892] [Reference Citation Analysis]
|
| 9 |
Maeda DLNF, Tian D, Yu H, Dar N, Rajasekaran V, Meng S, Mahsoub H, Sooryanarain H, Wang B, Heffron CL, Hassebroek A, Leroith T, Meng X, Zeichner SL. Killed whole genome-reduced bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.. [DOI: 10.1101/2021.03.15.435497] [Reference Citation Analysis]
|
| 10 |
Wiseman B, Nitharwal RG, Widmalm G, Högbom M. Structure of a full-length bacterial polysaccharide co-polymerase. Nat Commun 2021;12:369. [PMID: 33446644 DOI: 10.1038/s41467-020-20579-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 11 |
Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS. The Role of Vaccines in Combating Antimicrobial Resistance. Sustainable Agriculture Reviews 2021. [DOI: 10.1007/978-3-030-58259-3_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Braz VS, Melchior K, Moreira CG. Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium. Front Cell Infect Microbiol 2020;10:548492. [PMID: 33409157 DOI: 10.3389/fcimb.2020.548492] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 13 |
Li M, Shi D, Li Y, Xiao Y, Chen M, Chen L, Du H, Zhang W. Recombination of T4-like Phages and Its Activity against Pathogenic Escherichia coli in Planktonic and Biofilm Forms. Virol Sin 2020;35:651-61. [PMID: 32451882 DOI: 10.1007/s12250-020-00233-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 14 |
Silva E, Silva MF, Henriques S, Diniz P, Carneiro C, Lopes-da-costa L, Mateus L. The Role of Uteropathogenic Escherichia Coli in the Development of Canine Pyometra. Advances in Animal Health, Medicine and Production 2020. [DOI: 10.1007/978-3-030-61981-7_28] [Reference Citation Analysis]
|
| 15 |
Larzábal M, A. Cataldi A, A. Vilte D. Human and Veterinary Vaccines against Pathogenic Escherichia coli. The Universe of Escherichia coli [Working Title] 2019. [DOI: 10.5772/intechopen.82835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
[DOI: 10.1101/2020.06.14.148452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
